Catalog Number 112016 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Low Blood Pressure/ Hypotension (1914); Diminished Pulse Pressure (2606)
|
Event Date 08/26/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Oxiris has been temporarily approved for use in the us under emergency use authorization (b)(4) with a specific indication to treat patients with covid-19 infection.Reporter: address: (b)(6).Should additional relevant information become available, a supplemental report will be submitted.
|
|
Event Description
|
It was reported that five minutes into treatment with a prismaflex oxiris set, a patient experienced confusion, hypotension (with difficulty to measure blood pressure, therefore reading not reported) and a "discrete" pulse rate.Treatment was terminated and restarted using a prismaflex m100 set wih no further problems observed.No additional information is available.
|
|
Manufacturer Narrative
|
H10: the device was received for evaluation but could not be analyzed because the serological status of the patient was not provided.The reported condition was not verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|
|
Search Alerts/Recalls
|